Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TAO Synergies Inc.
Report date December 31, 2025 · Filed February 05, 2026
Section 16 reporting ended · disclosed 2026-02-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.38 · Expires 2035-07-14 | Direct | 2,000 |
Reported balance
After 2025-08-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-08-06 · Grant · Acquired 2,000 · Balance 2,000 F1: The option grant was approved by a committee of TAO Synergies Inc.'s (the "Issuer") board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Company's 2020 Equity Incentive Plan (the "Plan") to increase the number of shares authorized for issuance of awards under the Plan. The Company received shareholder approval of the amendment to the Plan on August 6, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The option grant was approved by a committee of TAO Synergies Inc.'s (the "Issuer") board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Company's 2020 Equity Incentive Plan (the "Plan") to increase the number of shares authorized for issuance of awards under the Plan. The Company received shareholder approval of the amendment to the Plan on August 6, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2025 Filed Feb 5, 2026 17:14 UTC | TAO Synergies Inc. TAOX · Entity 7482 | GrantEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $10.38 | $0.00 |
DisclosureSEC source: 0001104659-26-011067 · tm265390-1_5seq1.xml · derivative · entry 1 TUCHMAN ALAN J · CIK 0001417631 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2035-07-14 F1 · date: The option grant was approved by a committee of TAO Synergies Inc.'s (the "Issuer") board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Company's 2020 Equity Incentive Plan (the "Plan") to increase the number of shares authorized for issuance of awards under the Plan. The Company received shareholder approval of the amendment to the Plan on August 6, 2025. F1 · kind: The option grant was approved by a committee of TAO Synergies Inc.'s (the "Issuer") board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Company's 2020 Equity Incentive Plan (the "Plan") to increase the number of shares authorized for issuance of awards under the Plan. The Company received shareholder approval of the amendment to the Plan on August 6, 2025. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 16:05 UTC | TAO Synergies Inc. TAOX · Entity 7482 | Tax withholdingCommon Stock, par value $0.0001 per share | 1,726 | $7.85 | $13,549.10 |
DisclosureSEC source: 0001104659-25-065272 · tm2519649d1_4seq1.xml · nonDerivative · entry 2 TUCHMAN ALAN J · CIK 0001417631 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,909 F2 · shares: Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 16:05 UTC | TAO Synergies Inc. TAOX · Entity 7482 | GrantCommon Stock, par value $0.0001 per share | 4,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-065272 · tm2519649d1_4seq1.xml · nonDerivative · entry 1 TUCHMAN ALAN J · CIK 0001417631 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,635 F1 · balance_after: Includes (i) 4,315 restricted stock units granted on June 30, 2025, under the Issuer's 2020 Equity Incentive Plan which vested immediately upon issuance and (ii) 1,320 shares of common stock. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 20:00 UTC | TAO Synergies Inc. SNPX · Entity 7482 | SaleCommon Stock, par value $0.0001 per share | 27,000 | $1.17 | $31,641.30 |
DisclosureSEC source: 0001104659-22-128765 · tm2233089-1_4seq1.xml · nonDerivative · entry 1 TUCHMAN ALAN J · CIK 0001417631 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 F1 · shares: Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 16:01 UTC | TAO Synergies Inc. SNPX · Entity 7482 | GrantStock Option (Right to Buy) · Derivative | 112,000 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001104659-22-119876 · tm2230820-2_4seq1.xml · derivative · entry 1 TUCHMAN ALAN J · CIK 0001417631 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,000 Underlying: Common Stock, par value $0.0001 per share · 112,000 shares Expires 2032-11-15 F1 · derivative.exercise_date: These options vested 50% on November 15, 2022 (the "Issuance Date") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer. Read SEC document |
| November 15, 2022 Filed Dec 1, 2022 19:46 UTC Amendment | TAO Synergies Inc. SNPX · Entity 7482 | GrantStock Option (Right to Buy) · Derivative | 68,850 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001104659-22-123798 · tm2231816-1_4aseq1.xml · derivative · entry 1 TUCHMAN ALAN J · CIK 0001417631 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,850 Underlying: Common Stock, par value $0.0001 per share · 68,850 shares Expires 2032-11-15 F1 · shares: This filing amends the Form 4, filed on November 17, 2022 by Mr. Tuchman to reflect the lower number of options allowed to be granted pursuant to the per-participant grant limit contained in the Issuer's 2020 Equity Incentive Plan, as amended. F2 · derivative.exercise_date: These options vested 50% on November 15, 2022 (the "Issuance Date") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer. Read SEC document |
| February 16, 2022 Filed Feb 22, 2022 17:01 UTC | TAO Synergies Inc. SNPX · Entity 7482 | GrantStock Option (Right to Buy) · Derivative | 6,150 | $0.00 Strike: $7.29 | $0.00 |
DisclosureSEC source: 0001104659-22-025704 · tm227375-1_4seq1.xml · derivative · entry 1 TUCHMAN ALAN J · CIK 0001417631 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,150 Underlying: Common Stock · 6,150 shares Expires 2032-02-16 F1 · derivative.exercise_date: This option was issued on February 16, 2022 (the "Grant Date") under the Issuer's 2020 Equity Incentive Plan and will vest in equal quarterly installments over the four quarters following the Grant Date. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 18:08 UTC | TAO Synergies Inc. SNPX · Entity 7482 | GrantCommon Stock, par value $0.0001 per share | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-092722 · tm2122331-8_4seq1.xml · nonDerivative · entry 1 TUCHMAN ALAN J · CIK 0001417631 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F1 · balance_after: Includes 60,000 restricted stock units granted on July 13, 2021 (the "Grant Date") under the Issuer's 2020 Equity Incentive Plan which will vest 50% on the six month anniversary of the Grant Date and the remaining 50% on the one year anniversary of the Grant Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.